GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Electromed Inc (AMEX:ELMD) » Definitions » Return-on-Tangible-Equity

ELMD (Electromed) Return-on-Tangible-Equity : 13.92% (As of Sep. 2024)


View and export this data going back to 2010. Start your Free Trial

What is Electromed Return-on-Tangible-Equity?

Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Electromed's annualized net income for the quarter that ended in Sep. 2024 was $5.90 Mil. Electromed's average shareholder tangible equity for the quarter that ended in Sep. 2024 was $42.36 Mil. Therefore, Electromed's annualized Return-on-Tangible-Equity for the quarter that ended in Sep. 2024 was 13.92%.

The historical rank and industry rank for Electromed's Return-on-Tangible-Equity or its related term are showing as below:

ELMD' s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: 7.06   Med: 9.03   Max: 15.86
Current: 15.86

During the past 13 years, Electromed's highest Return-on-Tangible-Equity was 15.86%. The lowest was 7.06%. And the median was 9.03%.

ELMD's Return-on-Tangible-Equity is ranked better than
79.39% of 757 companies
in the Medical Devices & Instruments industry
Industry Median: 2.12 vs ELMD: 15.86

Electromed Return-on-Tangible-Equity Historical Data

The historical data trend for Electromed's Return-on-Tangible-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Electromed Return-on-Tangible-Equity Chart

Electromed Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Return-on-Tangible-Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 15.18 7.69 7.06 8.96 12.72

Electromed Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Return-on-Tangible-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.66 17.32 14.63 17.05 13.92

Competitive Comparison of Electromed's Return-on-Tangible-Equity

For the Medical Devices subindustry, Electromed's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Electromed's Return-on-Tangible-Equity Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Electromed's Return-on-Tangible-Equity distribution charts can be found below:

* The bar in red indicates where Electromed's Return-on-Tangible-Equity falls into.



Electromed Return-on-Tangible-Equity Calculation

Electromed's annualized Return-on-Tangible-Equity for the fiscal year that ended in Jun. 2024 is calculated as

Return-on-Tangible-Equity=Net Income/( (Total Tangible Equity+Total Tangible Equity)/ count )
(A: Jun. 2024 )  (A: Jun. 2023 )(A: Jun. 2024 )
=Net Income/( (Total Stockholders Equity - Intangible Assets+Total Stockholders Equity - Intangible Assets )/ count )
(A: Jun. 2024 )  (A: Jun. 2023 )(A: Jun. 2024 )
=5.15/( (37.062+43.888 )/ 2 )
=5.15/40.475
=12.72 %

Electromed's annualized Return-on-Tangible-Equity for the quarter that ended in Sep. 2024 is calculated as

Return-on-Tangible-Equity=Net Income/( (Total Tangible Equity+Total Tangible Equity)/ count )
(Q: Sep. 2024 )  (Q: Jun. 2024 )(Q: Sep. 2024 )
=Net Income/( (Total Stockholders Equity - Intangible Assets+Total Stockholders Equity - Intangible Assets)/ count )
(Q: Sep. 2024 )  (Q: Jun. 2024 )(Q: Sep. 2024 )
=5.896/( (43.888+40.828)/ 2 )
=5.896/42.358
=13.92 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Sep. 2024) net income data. Return-on-Tangible-Equity is displayed in the 10-year financial page.


Electromed  (AMEX:ELMD) Return-on-Tangible-Equity Explanation

Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.


Be Aware

Net Income is used.

Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.


Electromed Return-on-Tangible-Equity Related Terms

Thank you for viewing the detailed overview of Electromed's Return-on-Tangible-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Electromed Business Description

Traded in Other Exchanges
N/A
Address
500 Sixth Avenue NW, New Prague, MN, USA, 56071
Electromed Inc is a United States-based company that develops, manufactures, markets, and sells products that provide airway clearance therapy, including the SmartVest Airway Clearance System and related products, to patients with compromised pulmonary function with a commitment to excellence and compassionate service. The SmartVest System features a programmable air pulse generator, a therapy garment worn over the upper body and a connecting hose, which together provide safe, comfortable, and effective airway clearance therapy.
Executives
Andrew Summers director 601 JEFFERSON STREET, HOUSTON TX 77002
Kathleen Skarvan officer: Chief Executive Officer 40 WEST HIGHLAND PARK DR NE, HUTCHINSON MN 55350
James L. Cunniff director, officer: CEO and President 500 SIXTH AVE NW, NEW PRAGUE MN 56071
Bradley M. Nagel officer: Chief Financial Officer 500 SIXTH AVE NW, NEW PRAGUE MN 56071
Michelle C. Wirtz officer: Chief Financial Officer 500 SIXTH AVENUE NW,, NEW PRAGUE MN 56071
Christopher G. Holland officer: Chief Commercial Officer 500 SIXTH AVENUE NW, NEW PRAGUE MN 56071
Joseph L. Galatowitsch director 500 SIXTH AVENUE NW, NEW PRAGUE MN 56071
Kathleen A Tune director 60 SOUTH SIXTH STREET, SUITE 3620, MINNEAPOLIS MN 55402
A Jones Lee director 54 LOCKE LAKE RD, FRIDLEY MN 55432
Stephen H. Craney director 25340 SANDPIPER LANE, WINONA MN 55987
Andrea M. Walsh director 500 SIXTH AVENUE NW, NEW PRAGUE MN 56071
George H. Winn director 27451 COUNTRY HOLLOWS LANE, NEW PRAGUE MN 56701
Michael Joseph Maccourt officer: Chief Financial Officer 500 SIXTH AVENUE NW, NEW PRAGUE MN 56071
Gregory Fluet director 14405 21ST AVENUE NORTH, MINNEAPOLIS MN 55447
John L Erb director C/O VASCULAR SOLUTIONS, INC., 6464 SYCAMORE COURT N., MINNEAPOLIS, MN 55369

Electromed Headlines

From GuruFocus

Q1 2023 Electromed Inc Earnings Call Transcript

By GuruFocus Research 02-13-2024

Q3 2023 Electromed Inc Earnings Call Transcript

By GuruFocus Research 02-13-2024

Q3 2021 Electromed Inc Earnings Call Transcript

By GuruFocus Research 02-13-2024

Q1 2025 Electromed Inc Earnings Call Transcript

By GuruFocus News 11-13-2024

Q1 2022 Electromed Inc Earnings Call Transcript

By GuruFocus Research 02-13-2024

Electromed Inc Annual Shareholders Meeting Transcript

By GuruFocus Research 02-13-2024

Q4 2024 Electromed Inc Earnings Call Transcript

By GuruFocus Research 08-28-2024

Q2 2021 Electromed Inc Earnings Call Transcript

By GuruFocus Research 02-13-2024

Electromed Inc (ELMD) Stock Price Down 3.89% on Sep 10

By GuruFocus Research 09-10-2024